CD274 and plasma cell myeloma: Compared to B7-H1− human myeloma cell lines (HMCLs), B7-H1+ HMCLs were found to be more proliferative and less susceptible to dexamethasone and melphalan treatment and were accompanied by higher Bcl-2 and FasL expression [125, 126].